Japan · Delayed Price · Currency is JPY Organo Statistics
Total Valuation
Organo has a market cap or net worth of JPY 537.76 billion. The enterprise value is 547.29 billion.
| Market Cap | 537.76B |
| Enterprise Value | 547.29B |
Important Dates
The next estimated earnings date is Friday, October 30, 2026.
| Earnings Date | Oct 30, 2026 |
| Ex-Dividend Date | Sep 29, 2026 |
Share Statistics
Organo has 45.98 million shares outstanding. The number of shares has increased by 0.01% in one year.
| Current Share Class | 45.98M |
| Shares Outstanding | 45.98M |
| Shares Change (YoY) | +0.01% |
| Shares Change (QoQ) | +0.01% |
| Owned by Insiders (%) | 0.28% |
| Owned by Institutions (%) | 23.95% |
| Float | 24.62M |
Valuation Ratios
The trailing PE ratio is 19.07 and the forward PE ratio is 17.00.
| PE Ratio | 19.07 |
| Forward PE | 17.00 |
| PS Ratio | 2.96 |
| PB Ratio | 3.79 |
| P/TBV Ratio | 3.84 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 19.41 |
| EV / Sales | 3.01 |
| EV / EBITDA | 13.86 |
| EV / EBIT | 14.60 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.73, with a Debt / Equity ratio of 0.26.
| Current Ratio | 2.73 |
| Quick Ratio | 2.40 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 0.95 |
| Debt / FCF | n/a |
| Interest Coverage | 113.40 |
Financial Efficiency
Return on equity (ROE) is 21.58% and return on invested capital (ROIC) is 18.33%.
| Return on Equity (ROE) | 21.58% |
| Return on Assets (ROA) | 11.32% |
| Return on Invested Capital (ROIC) | 18.33% |
| Return on Capital Employed (ROCE) | 24.40% |
| Weighted Average Cost of Capital (WACC) | 10.37% |
| Revenue Per Employee | 68.37M |
| Profits Per Employee | 10.61M |
| Employee Count | 2,658 |
| Asset Turnover | 0.88 |
| Inventory Turnover | 5.01 |
Taxes
In the past 12 months, Organo has paid 10.37 billion in taxes.
| Income Tax | 10.37B |
| Effective Tax Rate | 26.88% |
Stock Price Statistics
The stock price has decreased by -4.41% in the last 52 weeks. The beta is 1.24, so Organo's price volatility has been higher than the market average.
| Beta (5Y) | 1.24 |
| 52-Week Price Change | -4.41% |
| 50-Day Moving Average | 13,946.40 |
| 200-Day Moving Average | 14,969.08 |
| Relative Strength Index (RSI) | 31.96 |
| Average Volume (20 Days) | 222,045 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Organo had revenue of JPY 181.73 billion and earned 28.20 billion in profits. Earnings per share was 613.20.
| Revenue | 181.73B |
| Gross Profit | 65.74B |
| Operating Income | 37.31B |
| Pretax Income | 38.56B |
| Net Income | 28.20B |
| EBITDA | 39.30B |
| EBIT | 37.31B |
| Earnings Per Share (EPS) | 613.20 |
Balance Sheet
The company has 27.84 billion in cash and 37.36 billion in debt, with a net cash position of -9.53 billion or -207.14 per share.
| Cash & Cash Equivalents | 27.84B |
| Total Debt | 37.36B |
| Net Cash | -9.53B |
| Net Cash Per Share | -207.14 |
| Equity (Book Value) | 141.89B |
| Book Value Per Share | 3,085.68 |
| Working Capital | 119.33B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 2.00B |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 36.17%, with operating and profit margins of 20.53% and 15.52%.
| Gross Margin | 36.17% |
| Operating Margin | 20.53% |
| Pretax Margin | 21.22% |
| Profit Margin | 15.52% |
| EBITDA Margin | 21.63% |
| EBIT Margin | 20.53% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 220.00, which amounts to a dividend yield of 1.75%.
| Dividend Per Share | 220.00 |
| Dividend Yield | 1.75% |
| Dividend Growth (YoY) | 16.85% |
| Years of Dividend Growth | 2 |
| Payout Ratio | n/a |
| Buyback Yield | -0.01% |
| Shareholder Yield | 1.73% |
| Earnings Yield | 5.24% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Organo is 20,700.00, which is 76.77% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 20,700.00 |
| Price Target Difference | 76.77% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 11.37% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on September 29, 2022. It was a forward split with a ratio of 4.
| Last Split Date | Sep 29, 2022 |
| Split Type | Forward |
| Split Ratio | 4 |
Scores
Organo has an Altman Z-Score of 7.52 and a Piotroski F-Score of 4.
| Altman Z-Score | 7.52 |
| Piotroski F-Score | 4 |